ID: ALA3085192

Max Phase: Preclinical

Molecular Formula: C39H64O13

Molecular Weight: 740.93

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[C@H]1CC[C@@]2(OC1)O[C@H]1C[C@H]3[C@@H]4CC[C@@H]5C[C@@H](O[C@@H]6O[C@@H](CO)[C@@H](O[C@@H]7O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]7O)[C@H](O)[C@@H]6O)CC[C@]5(C)[C@H]4CC[C@]3(C)C1[C@@H]2C

Standard InChI:  InChI=1S/C39H64O13/c1-18-7-12-39(47-17-18)19(2)28-25(52-39)14-24-22-6-5-20-13-21(8-10-37(20,3)23(22)9-11-38(24,28)4)48-35-33(46)31(44)34(27(16-41)50-35)51-36-32(45)30(43)29(42)26(15-40)49-36/h18-36,40-46H,5-17H2,1-4H3/t18-,19-,20+,21-,22+,23-,24-,25-,26-,27-,28?,29+,30-,31+,32-,33-,34+,35+,36-,37-,38-,39+/m0/s1

Standard InChI Key:  GUSVHVVOABZHAH-AYLFYDCTSA-N

Associated Targets(non-human)

Cricetinae gen. sp. 3197 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 740.93Molecular Weight (Monoisotopic): 740.4347AlogP: 1.44#Rotatable Bonds: 6
Polar Surface Area: 196.99Molecular Species: NEUTRALHBA: 13HBD: 7
#RO5 Violations: 3HBA (Lipinski): 13HBD (Lipinski): 7#RO5 Violations (Lipinski): 3
CX Acidic pKa: 11.94CX Basic pKa: CX LogP: 1.79CX LogD: 1.79
Aromatic Rings: 0Heavy Atoms: 52QED Weighted: 0.19Np Likeness Score: 2.56

References

1. DeNinno MP, McCarthy PA, Duplantier KC, Eller C, Etienne JB, Zawistoski MP, Bangerter FW, Chandler CE, Morehouse LA, Sugarman ED, Wilkins RW, Woody HA, Zaccaro LM..  (1997)  Steroidal glycoside cholesterol absorption inhibitors.,  40  (16): [PMID:9258361] [10.1021/jm9702600]

Source